Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Aug 11;107(9):djv218.
doi: 10.1093/jnci/djv218. Print 2015 Sep.

Response

B A M Heemskerk-Gerritsen  1 , M J Hooning  1 , M A Rookus  1 ; all authors
Affiliations
Comment

Response

B A M Heemskerk-Gerritsen et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cumulative breast cancer risk curves for BRCA1/2 mutation carriers (≥40 years) selected from the Hereditary Breast and Ovarian Cancer Research Group Netherlands cohort opting for risk-reducing salpingo-oophorectomy (RRSO) vs not opting for risk-reducing salpingo-oophorectomy (non-RRSO). *per 1000 person-years of observation. †Univariate analysis. The observation period started at the age of DNA result or the age of 40 years, whichever came first. A robust variance-covariance estimation method was used to correct for nonindependence of observations in women from the same family. BC = breast cancer; CI = confidence interval; HR = hazard ratio; PYO = person-years of observation; RRSO = risk-reducing salpingo-oophorectomy.
See this image and copyright information in PMC

Comment on

References

    1. Domchek SM, Friebel TM, Singer CF, et al. Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality. J Am Med Assoc. 2010;304 (9):967–975. - PMC - PubMed
    1. Kauff ND, Domchek SM, Friebel TM, et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study. J Clin Oncol. 2008;26 (8):1331–1337. - PMC - PubMed
    1. Heemskerk-Gerritsen BAM, Seynaeve C, van Asperen CJ, et al. Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. J Natl Cancer Inst. 2015;107 (5):djv033 doi:10.1093/jnci/djv033. - PubMed
    1. Mavaddat N, Peock S, Frost D, et al. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE. J Natl Cancer Inst. 2013;105 (11):812–822. - PubMed
    1. Simon R, Makuch RW. A Non-Parametric Graphical Representation of the Relationship between Survival and the Occurrence of an Event - Application to Responder Versus Non-Responder Bias. Stat Med. 1984;3 (1):35–44. - PubMed